{
    "clinical_study": {
        "@rank": "51970", 
        "arm_group": [
            {
                "arm_group_label": "Perilla extract", 
                "arm_group_type": "Experimental", 
                "description": "Experimental arm: Perilla extract"
            }, 
            {
                "arm_group_label": "Maltodextrin", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo arm: Maltodextrin"
            }
        ], 
        "brief_summary": {
            "textblock": "In the current study the effects of proprietary Perilla frutescens leaf extract in\n      comparison to Maltodextrin, a fully digestible carbohydrate (placebo control), on\n      gastrointestinal discomfort and bowel function were investigated. The study was performed\n      double-blind and placebo-controlled with a 4 week intervention period. Study products were\n      taken two times daily (each one capsule before breakfast and dinner)."
        }, 
        "brief_title": "Effect of Perilla Extract on Improvement on Gastrointestinal Discomfort", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Abdominal Pain/ Discomfort", 
            "Slightly Constipation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Abdominal Pain", 
                "Constipation"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy volunteers without clinical diagnosed diseases with relevant effect on the\n             gastrointestinal system or on visceral motility.\n\n          -  BMI: 19-30 kg/m2\n\n          -  Reduced bowel movements defined as an average of >1 and \u2264 3.5 stools per week for at\n             least the previous 6 months\n\n          -  Gastrointestinal symptoms of at least 5 points\n\n          -  Male or female\n\n          -  Age  \u2265 30 and \u2264 70 years\n\n          -  Nonsmoker\n\n          -  Written consent to participate in the study\n\n          -  Able and willing to follow the study protocol procedures\n\n        Exclusion Criteria:\n\n          -  Subject under prescription for medication for digestive symptoms such as\n             anti-spasmodic, laxatives and anti-diarrheic drugs or other digestive auxiliaries\n\n          -  Relevant history, presence of any medical disorder or intake of medication / dietary\n             supplements, potentially interfering with this trial at screening\n\n          -  Subjects with stool frequency of \u2264 1 stool every 7 days or > 3,5 stools per week\n\n          -  Subjects not willing to avoid pre- and probiotics for the duration of the study\n\n          -  Intake of antibiotics in the last 4 weeks and laxatives in the last 2 weeks\n\n          -  Change of dietary habits within the 4 weeks prior to screening (for instance start of\n             a diet high in fibers)\n\n          -  Pregnant subject or subject planning to become pregnant during the study;\n             breast-feeding subject.\n\n          -  Subjects with history of drug, alcohol or other substances abuse, or other factors\n             limiting their ability to co-operate during the study.\n\n          -  Participants anticipating a change in their lifestyle or physical activity levels\n             since this may also influence the results.\n\n          -  Known food intolerance or allergy.\n\n          -  Subject involved in any clinical or food study within the preceding month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "47", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01931930", 
            "org_study_id": "BTS656/12"
        }, 
        "intervention": [
            {
                "arm_group_label": "Perilla extract", 
                "intervention_name": "Perilla extract", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Maltodextrin", 
                "intervention_name": "Maltodextrin", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Gastrointestinal discomfort", 
            "Perilla frutescens", 
            "bloating", 
            "abdominal discomfort", 
            "human study", 
            "healthy subjects"
        ], 
        "lastchanged_date": "August 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Esslingen", 
                    "country": "Germany", 
                    "zip": "73728"
                }, 
                "name": "BioTeSys GmbH"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Perilla Extract on Improvement of Intestinal Discomfort and Bowel Function in Healthy Volunteers With Gastrointestinal Discomfort", 
        "overall_official": {
            "affiliation": "BioTeSys GmbH", 
            "last_name": "Daniel Menzel, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The following gastrointestinal were rated and reported by the study participants on a daily based. Bloating, rumbling, feeling of fullness, passage of gas, abdominal discomfort (pain and cramps). The rating was done based on a number scale. 0 not at all and 4 extremely.", 
            "measure": "daily gastrointestinal symptoms", 
            "safety_issue": "No", 
            "time_frame": "was assessed daily during 4 week intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01931930"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Three validated questionnaires were used. Two of them were specially designed to evaluate gastrointestinal symptoms and quality of life of people with constipation. The third questionnaire was a validated questionnaire to report stress levels and related changes of stress levels.\nPatient assessment of constipation symptoms (PAC SYM)\nPatents assessment of constipation quality of life (PAC QOL)\nPerceived stress questionnaire (PSQ20)", 
                "measure": "validated questionnaires", 
                "safety_issue": "No", 
                "time_frame": "assessed at visit 1 (before) and at visit 2 (after 4 week intervention)"
            }, 
            {
                "description": "The stool consistency was rated referring to the Bristol stool scale. A scale indicated with pictures how the stool consistency can be rated.", 
                "measure": "stool consistency", 
                "safety_issue": "No", 
                "time_frame": "reported at days with stool during 4 week intervention"
            }, 
            {
                "description": "All adverse events which might be linked to the study product were reported. As the tested study product is a food product being safe for consumption as food no specific parameter to define safety were defined.", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "assessed at visit 1 (before) and at visit 2 (after 4 week intervention)"
            }, 
            {
                "description": "The stool frequency was reported on each day with bowel movement.", 
                "measure": "Stool frequency", 
                "safety_issue": "No", 
                "time_frame": "reported at days with stool during 4 week intervention"
            }
        ], 
        "source": "Amino Up Chemicals Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Amino Up Chemicals Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}